New devices intended to help address the opioid crisis — ranging from a digitally controlled pill dispenser to a deep transcranial magnetic stimulation system — may soon be on the market, following their selection as winners of the FDA’s opioid innovation challenge.
The Food and Drug Administration selected eight devices as winners of the challenge, from a pool of about 250 applications submitted by medical device developers. The challenge winners will receive increased feedback from the FDA’s Center for Devices and Radiological Health, guidance for clinical ...
Comments